Literature DB >> 27829201

Management of breast cancer brain metastases: A practical review.

Claire Phillips1, Rosalind Jeffree2, Mustafa Khasraw3.   

Abstract

Brain metastases are a common, and frequently challenging, clinical problem in the contemporary management of metastatic breast cancer. While the management of extracranial metastatic breast cancer is now strongly defined by tumour phenotype, this approach is not so well defined for brain metastases. We review available evidence regarding management of brain metastases, including the limited breast-cancer-specific data. A framework for management according to breast cancer phenotype is proposed. Crown
Copyright © 2016. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Brain metastases; Breast cancer; Radiotherapy; Targeted therapy

Mesh：

Year:  2016        PMID： 27829201     DOI： 10.1016/j.breast.2016.10.006

Source DB:  PubMed          Journal:  Breast        ISSN： 0960-9776            Impact factor:   4.380


  7 in total

1.  Exceptional Responses to Standard Therapy in a Patient with Metastatic HER2-Positive Breast Cancer.

Authors:  Carsten Nieder; Bård Mannsåker; Ellinor Haukland
Journal:  Cureus       Date:  2017-06-29

Review 2.  Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases.

Authors:  Neal Shah; Afroz S Mohammad; Pushkar Saralkar; Samuel A Sprowls; Schuyler D Vickers; Devin John; Rachel M Tallman; Brandon P Lucke-Wold; Katherine E Jarrell; Mark Pinti; Richard L Nolan; Paul R Lockman
Journal:  Pharmacol Res       Date:  2018-03-28       Impact factor: 7.658

3.  Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis.

Authors:  Aadya Nagpal; Richard P Redvers; Xiawei Ling; Scott Ayton; Miriam Fuentes; Elnaz Tavancheh; Irmina Diala; Alshad Lalani; Sherene Loi; Steven David; Robin L Anderson; Yvonne Smith; Delphine Merino; Delphine Denoyer; Normand Pouliot
Journal:  Breast Cancer Res       Date:  2019-08-13       Impact factor: 6.466

4.  Factors affecting time to brain metastases for stage 2 and 3 breast cancer patients: A large single-institutional analysis with potential screening implications.

Authors:  Toni Q Cao; Karan Dixit; Cesar Santa-Maria; Priya Kumthekar
Journal:  Neurooncol Adv       Date:  2021-03-07

5.  Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer.

Authors:  Mao-Shan Chen; Peng-Cheng Liu; Jin-Zhi Yi; Li Xu; Tao He; Hao Wu; Ji-Qiao Yang; Qing Lv
Journal:  Sci Rep       Date:  2022-08-29       Impact factor: 4.996

6.  Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review.

Authors:  Giuseppina Rosaria Rita Ricciardi; Alessandro Russo; Tindara Franchina; Silvia Schifano; Giampiero Mastroeni; Anna Santacaterina; Vincenzo Adamo
Journal:  BMC Cancer       Date:  2018-01-25       Impact factor: 4.430

Review 7.  The management of elderly patients with brain metastases from breast cancer.

Authors:  Henry Ruiz-Garcia; Lina Marenco-Hillembrand; Jennifer L Peterson; Katherine Tzou; Timothy D Malouff; Kaisorn L Chaichana; Daniel M Trifiletti; Laura Vallow
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.